z-logo
open-access-imgOpen Access
HLA‐B*35–Restricted CD8 T Cell Epitopes in the Antigen 85 Complex ofMycobacterium tuberculosis
Author(s) -
Michèl R. Klein,
Steven M. Smith,
Abdulrahman S. Hammond,
Graham S. Ogg,
Abigail King,
Johan Vekemans,
Assan Jaye,
Pauline T. Lukey,
Keith P. W. J. McAdam
Publication year - 2001
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/319267
Subject(s) - epitope , mycobacterium tuberculosis , major histocompatibility complex , human leukocyte antigen , cd8 , antigen , biology , peptide , tuberculosis , cytotoxic t cell , immune system , t cell , antigen presentation , virology , immunology , medicine , biochemistry , in vitro , pathology
Few target epitopes have been described for human CD8 T lymphocytes in antigens of Mycobacterium tuberculosis. By use of a reverse immunogenetics approach, 23 motif-bearing peptides of the Ag85 complex were tested for binding to HLA-B*35, one of the common B-types in West Africa. Three 9-mer peptides bound with high affinity to HLA-B*3501 and displayed low dissociation rates of peptide-major histocompatibility complexes (MHCs). IC(50) and half-life values of peptide-MHC class I complexes were in the same range as reported earlier for other immunogenic peptides. Immune responses against peptide Ag85C (aa 204-212) WPTLIGLAM were characterized in detail. Peptide-stimulated effector cells were able to kill macrophages infected with M. tuberculosis or bacille Calmette-Guérin. Peptide-specific CD8 T cells could be visualized by using HLA-B*3501 tetramers and were shown to produce interferon-gamma and tumor necrosis factor-alpha. Together with other published epitopes, these peptides can be used to study more closely the role of CD8 T cells in mycobacterial infection and tuberculosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom